The plan for Public Investment Bank to take a 1% stake in Opella, for about EUR 150M, or $162.98M, came through a tri-party agreement between Sanofi, the French state and CD&R and was approved by ...

Sensex closed at 80,220.72, descended by 930.55 pts or 1.15%, and Nifty 50 ended the day’s trade ... Shares trade flat at ₹851.40 on the NSE. City Union Bank (CUB) stock surged 14 per cent ...

The French pharmaceutical group’s board is scheduled to meet to discuss the planned transaction and finalize measures with CD&R to protect jobs and local plants, the people said, asking not to ...

NEW YORK, Nov. 11, 2024 /PRNewswire/ -- Clayton, Dubilier & Rice ("CD&R" or the "Firm") today announced that Bill Galvin has been engaged as an Operating Advisor to CD&R funds. Mr. Galvin is a 36 ...

The renewed negotiations come after CD&R agreed to pledges around local jobs, investments and production, Bloomberg reported earlier. Sanofi encountered a backlash in France when it chose the US ...

The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than cutting costs. Chris Hughes is a Bloomberg Opinion columnist covering ...

Dulcolax and IcyHot--to CD&R, French state-owned investment bank Bpifrance take a stake of about 2% in the unit and Sanofi retain the remaining 48%, Sanofi said Monday. The move to enter ...

French public investment bank Bpifrance is expected to become a minority shareholder, taking a stake of around 2%, said Sanofi in a statement, and giving the state a seat on Opella's board.

French pharmaceutical group Sanofi and US private equity firm Clayton Dubilier & Rice (CD&R) have entered exclusive negotiations regarding the partial takeover of Sanofi subsidiary Opella.

Sanofi said on Monday (Oct 21) it had entered exclusive talks for the sale of a 50 per cent controlling stake in its consumer health business Opella to US private equity firm Clayton Dubilier & Rice ...

Global investment firm CD&R on Monday announced an open offer to acquire a 26 per cent stake in Sanofi Consumer Healthcare India Ltd for an aggregate of up to Rs 2,983 crore. The development follows ...